On May 23, 2018, we published revised versions of our Privacy Policy and User Agreements. Please read these updated terms and take some time to understand them. Your use of our services is subject to these revised terms.
Yes, I Agree.
Save 20% on Press Releases and More with NNW Prime! Click to View Details
FridayAug 19, 2016 9:31 am

Sky Solar Holdings, Ltd. (SKYS) Announces Letter of Intent to Sell Assets Held by Japanese Subsidiary

In a recent news release, Sky Solar Holdings, Ltd. (NASDAQ: SKYS), a leading global developer and operator of solar parks, announced its entry into a letter of intent with Solar Partnership Capital Ltd. (“SPC”) through which the latter intends to acquire interests in 152 MW of solar projects from Sky Solar Japan K.K. (“SSJ”). All related projects are classified as operating stage, under-construction, or ‘shovel-ready’. According to the terms of the agreement, SPC has agreed to assume a collection of specified liabilities associated with the SSJ solar projects in exchange for a total purchase price of roughly $165 million. Proceeds…

Continue Reading

ThursdayAug 18, 2016 1:04 pm

Fuel Tech, Inc. (FTEK) Tech Marketing/Supply Deals Enhance Emission Control Systems Portfolio

For a developer of proprietary, state-of-the-art, multi-pollutant control technologies such as Illinois-headquartered Fuel Tech (NASDAQ: FTEK), which has a footprint spanning the gamut from air pollution control (APC) and combustion efficiency, to process optimization and advanced engineering services (like boiler tuning or selective catalytic reduction optimization) – staying ahead of the regulatory game has become second nature. Utility and industrial customers have grown to rely on the Fuel Tech name when it comes to tackling increasingly stringent emission requirements, whether we are talking NOx (nitrogen oxides) control in combustion systems, or pollutants such as mercury. Much of the company’s prowess…

Continue Reading

ThursdayAug 18, 2016 12:41 pm

Monaker Group, Inc. (MKGI) Announces Launch of Premium Service for Property Owners

Earlier today, Monaker Group, Inc. (OTCQB: MKGI) announced the launch of its new Premium Service for owners of alternative lodging listings, which is designed to even the playing field between homeowners and travel industry suppliers. According to the news release, major travel industry suppliers – including airlines, hotels and car rental companies – employ cutting-edge tools that allow them to actively manage their rates on a minute-by-minute basis in order to react to competitive pricing, utilization and other market conditions. As a result, these suppliers are able to efficiently maximize revenues. Using Monaker’s Premium Service, individual property owners can enjoy…

Continue Reading

ThursdayAug 18, 2016 9:12 am

Radius Health, Inc. (RDUS) Announces Positive Results of Phase 3 ACTIVE Trial Published in JAMA

Radius Health, Inc. (NASDAQ: RDUS), a biopharmaceutical company committed to developing unique therapeutics in osteoporosis, oncology, and endocrine diseases, recently announced that the positive results of it phase 3 ACTIVE trial were published in the Journal of the American Medical Association (JAMA). ACTIVE stands for Abaloparatide Comparator Trial InVertebral Endpoints. Abaloparatide is a drug being trialed for the treatment of postmenopausal women with osteoporosis. The trial involved 2,463 patients and was put in place to establish whether or not the drug was both safe and efficient. In a news release, Dr. Paul Miller, medical director of the Colorado Center for…

Continue Reading

WednesdayAug 17, 2016 3:49 pm

Mondelez International, Inc. (MDLZ) Enters Licensing Agreement for Cadbury-Branded Biscuits

In a recent news release, Mondelez International, Inc. (NASDAQ: MDLZ), a global snacking powerhouse, announced an agreement with Burton’s Biscuit Company that will, pending regulatory approval, enable the company to manufacture, market and sell Cadbury-branded biscuits in a number of international markets, including the UK, France, Ireland, North America and Saudi Arabia. This landmark announcement is expected to facilitate accelerated biscuit growth for Mondelez in key markets around the globe, providing a platform to expand upon its position as a world leader in biscuits and chocolate. “Ownership of the Cadbury biscuits license offers us exciting opportunities to accelerate global growth…

Continue Reading

WednesdayAug 17, 2016 9:02 am

The ONE Group Hospitality, Inc. (STKS) Signs $3 Million Loan Agreement

On Friday August 12, 2016, the ONE Group Hospitality, Inc. (NASDAQ: STKS) disclosed that it had issued an unsecured 5-year promissory note to Anson Investments Master Fund LP, the consideration for which is $3 million to be used for development. Interest on the note is payable quarterly at an annual rate of 10 percent, with the first payment due on September 30, 2016. The maturity date of the note is August 11, 2021. Under the terms of the loan agreement, the ONE Group Hospitality, Inc. has issued a warrant that gives Anson Investments Master Fund LP the right, but not…

Continue Reading

TuesdayAug 16, 2016 11:40 am

Misonix, Inc. (MSON) Teams with SonoSpine, LLC to Advance Ultrasonic Technology

In a recent news release, Misonix, Inc. (NASDAQ: MSON), a leading manufacturer and marketer of therapeutic ultrasonic medical devices, announced its entry into a partnership with SonoSpine, LLC, an international neurosurgical practice specializing in ultrasonic spine surgery. Through this agreement, the two companies will look to leverage innovative devices and a revolutionary approach to spine surgery to accelerate the development and application of next generation ultrasonic surgery. Misonix will be granted access to SonoSpine’s clinical facilities in order to gain insight into ultrasonic therapies from the surgeon’s perspective, and the two companies will create a joint clinical database to support…

Continue Reading

TuesdayAug 16, 2016 9:59 am

Cellectar Biosciences, Inc. (CLRB) Announces Corporate Highlights and Financial Results for Q2 2016

Cellectar Biosciences, Inc. (NASDAQ: CLRB) recently announced (http://nnw.fm/I70Ox) its corporate highlights for this quarter and financial results for Q2 2016, which ended on June 30 of this year. One of the company’s key accomplishments was the issuance of several patents from USPTO, including CLR 131 and other radiotherapeutics used in the treatment of cancerous cells, as well as the CLR 1600 series. In addition to these, the company shared the results of its preclinical study of 1602, and announced the completion of the first phase of the NCI SBIR fast track grant. CLRB also closed $8 million in financing and…

Continue Reading

TuesdayAug 16, 2016 9:36 am

Monaker Group, Inc. (MKGI) Enters Agreement with Trisept Solutions to Fuel Growth

Before the opening bell, Monaker Group, Inc. (OTCQB: MKGI) announced a new agreement with Trisept Solutions, a division of The Mark Travel Corporation. Through this partnership, Trisept will both power Monaker’s flagship NextTrip.com brand with its Synapse travel merchandising platform and distribute its alternative lodging inventory through VAX VacationAccess, Trisept’s premier travel agent portal. This agreement is expected to fuel NextTrip’s forward growth by enabling expanded product offerings and distribution in the months to come. “Trisept has the most advanced technology available for leisure vacation packaging today,” Bill Kerby, chairman and chief executive officer of Monaker, stated in this morning’s…

Continue Reading

MondayAug 15, 2016 10:18 am

Celsion Corporation (CLSN) and Zhejiang Hisun Pharmaceutical Company Expand Partnership with GEN-1 Agreement

On Tuesday August 8, 2016, Lawrenceville, New Jersey-based Celsion Corporation (NASDAQ: CLSN), a company focused on developing a portfolio of innovative cancer treatments, announced the commencement of a Technology Transfer, Manufacturing and Commercial Supply Agreement with Zhejiang Hisun Pharmaceutical Co. Ltd., a leading pharmaceutical company in China, relating to the production for clinical and commercial purposes of GEN-1, Celsion’s proprietary gene mediated IL-12 immunotherapy. The agreement comes four years after a similar one for ThermoDox®, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin. The agreement gives Celsion a domestically-based partner as it engages with the China Food and Drug Administration (CFDA)…

Continue Reading

NetworkNewsWire Currently Accepts

Bitcoin

Bitcoin

Bitcoin Cash

Bitcoin Cash

Doge Coin

Dogecoin

Ethereum

Ethereum

Litecoin

Litecoin

USD Coin

USD Coin

Contact us: 212.418.1217